Triumph Capital Management »

Sinovac Biotech shares owned by Triumph Capital Management

Quarter-by-quarter ownership of Sinovac Biotech shares owned by Triumph Capital Management from 13F filings

Historical chart of Triumph Capital Management investment in Sinovac Biotech

Tip: Access up to 7 years of quarterly data

All positions including Sinovac Biotech held by Triumph Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sinovac Biotech by Triumph Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $0 14 0.00

More positions owned by Triumph Capital Management

Apple (AAPL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange-traded First Tr Enh New (FTSM)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Dimensional Etf Trust Short Duration F (DFSD)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core S&p500 Etf (IVV)
First Tr Exchange-traded Fst Low Oppt Eft (LMBS)
Ishares Tr Usd Inv Grde Etf (USIG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Innovator Etfs Trust Quity Managd Flr (SFLR)
First Tr Exchange-traded A Com Shs (FEX)

View all positions for Triumph Capital Management

Top funds holding Sinovac Biotech

Vivo Capital
OrbiMed Advisors
Renaissance Technologies
Neumann Advisory Hong Kong
CalPERS
Skandinaviska Enskilda Banken AB
Spark Investment Management
Geode Capital Management
Susquehanna International
Morgan Stanley
Wells Fargo & Company
UBS Group
Advisor Group Holdings
Northwestern Mutual Wealth Management Company
Atlantic Edge Private Wealth Management

View all funds holding Sinovac Biotech